$BIIB News U.S. stocks rise; SP 500 positive for
Post# of 144482
Posted On: 03/18/2014 11:38:40 AM
$BIIB News
U.S. stocks rise; S&P 500 positive for the year 4:40 p.m. March 17, 2014 - Anora Mahmudova
Yahoo gains on Alibaba IPO; Plug Power loses momentum 4:17 p.m. March 17, 2014 - Sue Chang
Keurig Green Mountain added to S&P 500 index 9:56 a.m. March 15, 2014 - MarketWatch.com
From every angle, technicals point to richer stocks 2:26 p.m. March 11, 2014 - The Trading Deck
Stocks close mostly higher after jobs report beats forecasts: stock market live blog recap 5:03 p.m. March 7, 2014 - blogs.marketwatch.com
Winning approval for new drugs may get harder, analyst warns 4:56 p.m. Feb. 28, 2014 - Russ Britt
Utility stocks gain as Treasury yields lag 5:06 p.m. Feb. 4, 2014 - Wallace Witkowski
Biogen Idec investors focus on positive, ignore outlook for 2014 3:02 p.m. Jan. 29, 2014 - Russ Britt
Biogen profit jumps on MS treatment revenue 8:09 a.m. Jan. 29, 2014 - MarketWatch.com
Stock investors trash market darlings, face Apple, Fed 9:01 a.m. Jan. 26, 2014 - Wallace Witkowski
The market puts a few feathers in its cap 2:58 p.m. Jan. 23, 2014 - The Trading Deck
Speculators turn the heat up to ‘soft boil’ 4:55 p.m. Jan. 16, 2014 - The Trading Deck
GameStop tumbles 20%; Tesla surges on strong sales 5:23 p.m. Jan. 14, 2014 - Sue Chang
Beam up on Suntory deal; Elliott report lifts Juniper 5:18 p.m. Jan. 13, 2014 - Sue Chang
Biogen, Sangamo partner on hemoglobin therapies 10:39 a.m. Jan. 9, 2014 - MarketWatch.com
Earnings boost Micron, drag on Container Store 5:25 p.m. Jan. 8, 2014 - Sue Chang
Goldman's biotech downgrade and the new consensus 12:53 p.m. Jan. 6, 2014 - MarketWatch.com
Charting a bullish year-end backdrop 1:29 p.m. Dec. 17, 2013 - Michael Ashbaugh
Charting a bullish year-end backdrop 1:03 p.m. Dec. 17, 2013 - Michael Ashbaugh
Get your portfolio to turn the corner 3:33 p.m. Dec. 10, 2013 - The Trading Deck
The Move Down In Berry Plastics Is Half Over From My Perspective 9:40 a.m. Today - Seeking Alpha
FDA delays decision on Biogen's Plegridy MS treatment 8:42 a.m. Today - Seeking Alpha
Veteran Investor's Top Biotech and Drug Stocks 7:07 a.m. Today - Barrons.com
Stocks Rally Amid Rise in Factory Production; Lack of Ukraine Violence 4:36 p.m. March 17, 2014 - TheStreet.com
Keurig Green Mountain, Biogen Shares Rally Following Additions to S&P Indices? 12:06 p.m. March 17, 2014 - benzinga.com
Biogen Idec (BIIB) Showing Signs Of Being A Momo Momentum Stock 11:07 a.m. March 17, 2014 - TheStreet.com
Jim Cramer's Mad Dash: HTZ REGN 10:41 a.m. March 17, 2014 - TheStreet.com
Keurig Green Mountain Pops on S&P 500 Invite 9:15 a.m. March 17, 2014 - FOXBusiness
American Funds: 5 Mutual Funds to Buy 4:34 a.m. March 17, 2014 - InvestorPlace.com
Cramer's Mad Money - China Is No Problem For General Electric Long-Term (3/14/14) 6:24 a.m. March 16, 2014 - Seeking Alpha
'Mad Money' Lightning Round: You Have to Own GE 6:00 a.m. March 15, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan 8:24 p.m. March 14, 2014 - TheStreet.com
MultiStem Overshadows Q4 Loss at Athersys - Analyst Blog 3:31 p.m. March 14, 2014 - Zacks.com
AVEO Q4 Loss Narrower than Expected - Analyst Blog 9:10 a.m. March 14, 2014 - Zacks.com
Wider Q4 Loss at Keryx - Analyst Blog 1:19 p.m. March 13, 2014 - Zacks.com
Fate Therapeutics' Prohema in Phase II Study - Analyst Blog 11:50 a.m. March 13, 2014 - Zacks.com
Myriad Genetics Down on Court Ruling - Analyst Blog 3:30 p.m. March 12, 2014 - Zacks.com
Biotech Stock Roundup: Amgen, Regeneron Slide on PCSK9 Inhibitor Concerns - Analyst Blog 10:50 a.m. March 12, 2014 - Zacks.com
BioMarin, Medivation Buck Biotech Short Interest Trend (BIIB, BMRN, MDVN) 9:01 a.m. March 12, 2014 - benzinga.com
Gilead Sciences' Novel Leukemia Drug Should Extend Company Profits 4:47 p.m. March 11, 2014 - Seeking Alpha
Biogen Idec Receives Notification of PDUFA Date Extension for Plegridy™(Peginterferon Beta-1a) 7:30 a.m. Today - BusinessWire - BZX
Biogen Idec Set to Join the S&P 100; Keurig Green Mountain to Join the S&P 500; Changes to the S&P MidCap 400 and the S&P SmallCap 600 5:58 p.m. March 14, 2014 - PR Newswire - PRF
Collaborations, Treatment Approvals, New Solutions, Clinical Trial Results, and New Drug Applications - Analyst Notes on Biogen Idec, Johnson & Johnson, Express Scripts, Merck, and Forest Laboratories 8:00 a.m. March 12, 2014 - PR Newswire - PRF
RBCC: Analyst Rates n3D a Leading Stakeholder in Explosive Bioprinting Industry 5:00 a.m. March 6, 2014 - BusinessWire - BZX
Global Biosimilars Market 2014-2018 10:28 a.m. Feb. 27, 2014 - PR Newswire - PRF
Critical Alerts For Walter Energy, Regeneron, Biogen Idec, Red Hat, and Level 3 Communications Released By InvestorsObserver 9:31 a.m. Feb. 27, 2014 - PR Newswire - PRF
WuXi PharmaTech Announces Appointment of Dr. Hua Mu to Head Product Development Service and Partnership Business Unit 9:33 a.m. Feb. 26, 2014 - PR Newswire - PRF
RBCC Increases Foothold in 3D Bioprinting Market 7:49 a.m. Feb. 26, 2014 - BusinessWire - BZX
Biogen Idec to Present at the Cowen & Company 34th Annual Health Care Conference 4:01 p.m. Feb. 25, 2014 - BusinessWire - BZX
SciQuest Customers to Discuss Procurement Transformation in Action at NextLevel 2014 8:35 a.m. Feb. 24, 2014 - BusinessWire - BZX
RBCC: New Innovations Spur Demand for 3D Printing in Medicine 5:00 a.m. Feb. 20, 2014 - BusinessWire - BZX
Biogen Idec to Present at the 2014 RBC Capital Markets’ Healthcare Conference 4:01 p.m. Feb. 18, 2014 - BusinessWire - BZX
New Product Puts RBCC on Leading Edge of Organ Regeneration Research 5:00 a.m. Feb. 18, 2014 - BusinessWire - BZX
William D. Young To Retire From Biogen Idec’s Board of Directors 1:50 p.m. Feb. 15, 2014 - BusinessWire - BZX
Isis Pharmaceuticals Advances ISIS-SMN Rx in Infants and Children with Spinal Muscular Atrophy 7:00 a.m. Feb. 13, 2014 - PR Newswire - PRF
Brazilian Pharmaceutical Market 2014-2024 10:03 a.m. Feb. 12, 2014 - PR Newswire - PRF
RBCC Seeks Out Capital Partners for 3D Bioprinting Expansion 5:00 a.m. Feb. 6, 2014 - BusinessWire - BZX
Cleave Biosciences Names Alessandra Cesano as Chief Medical Officer and Lewis Shuster as Director 8:00 a.m. Feb. 4, 2014 - PR Newswire - PRF
TECFIDERA® (Dimethyl Fumarate) Approved in the European Union as a First-Line Oral Treatment for Multiple Sclerosis 9:33 a.m. Feb. 3, 2014 - BusinessWire - BZX
TECFIDERA® (Dimethyl Fumarate) Approved in the European Union as a First-Line Oral Treatment for Multiple Sclerosis 8:53 a.m. Feb. 3, 2014 - BusinessWire - BZX
U.S. stocks rise; S&P 500 positive for the year 4:40 p.m. March 17, 2014 - Anora Mahmudova
Yahoo gains on Alibaba IPO; Plug Power loses momentum 4:17 p.m. March 17, 2014 - Sue Chang
Keurig Green Mountain added to S&P 500 index 9:56 a.m. March 15, 2014 - MarketWatch.com
From every angle, technicals point to richer stocks 2:26 p.m. March 11, 2014 - The Trading Deck
Stocks close mostly higher after jobs report beats forecasts: stock market live blog recap 5:03 p.m. March 7, 2014 - blogs.marketwatch.com
Winning approval for new drugs may get harder, analyst warns 4:56 p.m. Feb. 28, 2014 - Russ Britt
Utility stocks gain as Treasury yields lag 5:06 p.m. Feb. 4, 2014 - Wallace Witkowski
Biogen Idec investors focus on positive, ignore outlook for 2014 3:02 p.m. Jan. 29, 2014 - Russ Britt
Biogen profit jumps on MS treatment revenue 8:09 a.m. Jan. 29, 2014 - MarketWatch.com
Stock investors trash market darlings, face Apple, Fed 9:01 a.m. Jan. 26, 2014 - Wallace Witkowski
The market puts a few feathers in its cap 2:58 p.m. Jan. 23, 2014 - The Trading Deck
Speculators turn the heat up to ‘soft boil’ 4:55 p.m. Jan. 16, 2014 - The Trading Deck
GameStop tumbles 20%; Tesla surges on strong sales 5:23 p.m. Jan. 14, 2014 - Sue Chang
Beam up on Suntory deal; Elliott report lifts Juniper 5:18 p.m. Jan. 13, 2014 - Sue Chang
Biogen, Sangamo partner on hemoglobin therapies 10:39 a.m. Jan. 9, 2014 - MarketWatch.com
Earnings boost Micron, drag on Container Store 5:25 p.m. Jan. 8, 2014 - Sue Chang
Goldman's biotech downgrade and the new consensus 12:53 p.m. Jan. 6, 2014 - MarketWatch.com
Charting a bullish year-end backdrop 1:29 p.m. Dec. 17, 2013 - Michael Ashbaugh
Charting a bullish year-end backdrop 1:03 p.m. Dec. 17, 2013 - Michael Ashbaugh
Get your portfolio to turn the corner 3:33 p.m. Dec. 10, 2013 - The Trading Deck
The Move Down In Berry Plastics Is Half Over From My Perspective 9:40 a.m. Today - Seeking Alpha
FDA delays decision on Biogen's Plegridy MS treatment 8:42 a.m. Today - Seeking Alpha
Veteran Investor's Top Biotech and Drug Stocks 7:07 a.m. Today - Barrons.com
Stocks Rally Amid Rise in Factory Production; Lack of Ukraine Violence 4:36 p.m. March 17, 2014 - TheStreet.com
Keurig Green Mountain, Biogen Shares Rally Following Additions to S&P Indices? 12:06 p.m. March 17, 2014 - benzinga.com
Biogen Idec (BIIB) Showing Signs Of Being A Momo Momentum Stock 11:07 a.m. March 17, 2014 - TheStreet.com
Jim Cramer's Mad Dash: HTZ REGN 10:41 a.m. March 17, 2014 - TheStreet.com
Keurig Green Mountain Pops on S&P 500 Invite 9:15 a.m. March 17, 2014 - FOXBusiness
American Funds: 5 Mutual Funds to Buy 4:34 a.m. March 17, 2014 - InvestorPlace.com
Cramer's Mad Money - China Is No Problem For General Electric Long-Term (3/14/14) 6:24 a.m. March 16, 2014 - Seeking Alpha
'Mad Money' Lightning Round: You Have to Own GE 6:00 a.m. March 15, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan 8:24 p.m. March 14, 2014 - TheStreet.com
MultiStem Overshadows Q4 Loss at Athersys - Analyst Blog 3:31 p.m. March 14, 2014 - Zacks.com
AVEO Q4 Loss Narrower than Expected - Analyst Blog 9:10 a.m. March 14, 2014 - Zacks.com
Wider Q4 Loss at Keryx - Analyst Blog 1:19 p.m. March 13, 2014 - Zacks.com
Fate Therapeutics' Prohema in Phase II Study - Analyst Blog 11:50 a.m. March 13, 2014 - Zacks.com
Myriad Genetics Down on Court Ruling - Analyst Blog 3:30 p.m. March 12, 2014 - Zacks.com
Biotech Stock Roundup: Amgen, Regeneron Slide on PCSK9 Inhibitor Concerns - Analyst Blog 10:50 a.m. March 12, 2014 - Zacks.com
BioMarin, Medivation Buck Biotech Short Interest Trend (BIIB, BMRN, MDVN) 9:01 a.m. March 12, 2014 - benzinga.com
Gilead Sciences' Novel Leukemia Drug Should Extend Company Profits 4:47 p.m. March 11, 2014 - Seeking Alpha
Biogen Idec Receives Notification of PDUFA Date Extension for Plegridy™(Peginterferon Beta-1a) 7:30 a.m. Today - BusinessWire - BZX
Biogen Idec Set to Join the S&P 100; Keurig Green Mountain to Join the S&P 500; Changes to the S&P MidCap 400 and the S&P SmallCap 600 5:58 p.m. March 14, 2014 - PR Newswire - PRF
Collaborations, Treatment Approvals, New Solutions, Clinical Trial Results, and New Drug Applications - Analyst Notes on Biogen Idec, Johnson & Johnson, Express Scripts, Merck, and Forest Laboratories 8:00 a.m. March 12, 2014 - PR Newswire - PRF
RBCC: Analyst Rates n3D a Leading Stakeholder in Explosive Bioprinting Industry 5:00 a.m. March 6, 2014 - BusinessWire - BZX
Global Biosimilars Market 2014-2018 10:28 a.m. Feb. 27, 2014 - PR Newswire - PRF
Critical Alerts For Walter Energy, Regeneron, Biogen Idec, Red Hat, and Level 3 Communications Released By InvestorsObserver 9:31 a.m. Feb. 27, 2014 - PR Newswire - PRF
WuXi PharmaTech Announces Appointment of Dr. Hua Mu to Head Product Development Service and Partnership Business Unit 9:33 a.m. Feb. 26, 2014 - PR Newswire - PRF
RBCC Increases Foothold in 3D Bioprinting Market 7:49 a.m. Feb. 26, 2014 - BusinessWire - BZX
Biogen Idec to Present at the Cowen & Company 34th Annual Health Care Conference 4:01 p.m. Feb. 25, 2014 - BusinessWire - BZX
SciQuest Customers to Discuss Procurement Transformation in Action at NextLevel 2014 8:35 a.m. Feb. 24, 2014 - BusinessWire - BZX
RBCC: New Innovations Spur Demand for 3D Printing in Medicine 5:00 a.m. Feb. 20, 2014 - BusinessWire - BZX
Biogen Idec to Present at the 2014 RBC Capital Markets’ Healthcare Conference 4:01 p.m. Feb. 18, 2014 - BusinessWire - BZX
New Product Puts RBCC on Leading Edge of Organ Regeneration Research 5:00 a.m. Feb. 18, 2014 - BusinessWire - BZX
William D. Young To Retire From Biogen Idec’s Board of Directors 1:50 p.m. Feb. 15, 2014 - BusinessWire - BZX
Isis Pharmaceuticals Advances ISIS-SMN Rx in Infants and Children with Spinal Muscular Atrophy 7:00 a.m. Feb. 13, 2014 - PR Newswire - PRF
Brazilian Pharmaceutical Market 2014-2024 10:03 a.m. Feb. 12, 2014 - PR Newswire - PRF
RBCC Seeks Out Capital Partners for 3D Bioprinting Expansion 5:00 a.m. Feb. 6, 2014 - BusinessWire - BZX
Cleave Biosciences Names Alessandra Cesano as Chief Medical Officer and Lewis Shuster as Director 8:00 a.m. Feb. 4, 2014 - PR Newswire - PRF
TECFIDERA® (Dimethyl Fumarate) Approved in the European Union as a First-Line Oral Treatment for Multiple Sclerosis 9:33 a.m. Feb. 3, 2014 - BusinessWire - BZX
TECFIDERA® (Dimethyl Fumarate) Approved in the European Union as a First-Line Oral Treatment for Multiple Sclerosis 8:53 a.m. Feb. 3, 2014 - BusinessWire - BZX
(0)
(0)Scroll down for more posts ▼